Pharma Contractor ApS: Financial statements 2022
CVR: 42247693
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Pharma Contractor ApS (CVR 42247693) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 1,889,560 and a net result of DKK 584,810. Equity in the 2022 report amounted to DKK 539,810. The solvency ratio was 67.8%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 1,889,560
- Profit/Loss
- DKK 584,810
- Equity
- DKK 539,810
- Total Assets
- DKK 796,421
- Employees
- 2
Official annual report
Keep an eye on Pharma Contractor ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Pharma Contractor ApS has published its interim report for the period March 24, 2021 to December 31, 2021.
About Pharma Contractor ApS
Pharma Contractor ApS is a Danish company of the type Anpartsselskab based in Brøndby, founded in 2021. The company is registered under the industry Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik. The management consists of Samina Anwar and Mohammad Masood Anwar. The company is owned by Anwars Holding ApS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 2,561,002 and a net result of DKK 1,174,130 compared with DKK 1,438,311 the year before. Equity in the 2025 report amounted to DKK 1,146,081.
